文献速递主动脉疾病

胸腹主动脉瘤腔内修复术后结局的性别差异

Sex-related outcomes following endovascular repair of thoracoabdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2026-01-30

基于血管质量倡议数据库2014-2020年1128例I-IV型胸腹主动脉瘤复杂腔内修复患者,女性占37%。女性动脉瘤更广泛、症状性比例更高、二级预防用药更少,30天死亡率(11.8% vs 6.6%)和并发症更高,1年生存率更低(74% vs 82%)。

要点

  • 女性胸腹主动脉瘤腔内修复术后30天死亡率和并发症显著高于男性
  • 女性1年生存率更低(74% vs 82%),主要由30天死亡率差异驱动
  • 女性动脉瘤更广泛、症状性更多、二级预防用药不足,需性别特异性管理

核心结论

  • 女性I-IV型胸腹主动脉瘤复杂腔内修复术后30天并发症和死亡率更高,1年生存率更低。
  • 女性性别是30天和1年死亡率的独立危险因素。

研究设计与样本

  • 回顾性队列研究,使用血管质量倡议数据库2014-2020年数据。
  • 共纳入1128例接受I-IV型胸腹主动脉瘤复杂腔内修复的患者,女性417例(37%)。
  • 比较女性和男性的 demographic、术前、术中变量及术后结局,并利用长期随访数据比较1年生存率。

主要发现

  • 女性动脉瘤更广泛(84.7% vs 72.4% 为I-III型;P < .001),症状性动脉瘤更多(26.1% vs 18.4%;P = .002)。
  • 女性阿司匹林(59.4% vs 67.4%;P = .019)和他汀(65.1% vs 73.1%;P = .012)使用率更低,当前吸烟比例更高(36.1% vs 30.7%;P = .052)。
  • 女性最大直径超过推荐修复阈值更多(7.7 mm vs 4.6 mm;P < .001)。
  • 女性分期修复更多(22.3% vs 16.6%;P = .018),髂股入路复杂更多(19.2% vs 10.3%;P < .001),入路并发症更高(8.9% vs 5.2%;P = .016)。
  • 女性30天死亡率(11.8% vs 6.6%;P = .003)、总体并发症(35.7% vs 25.7%;P < .001)和永久性脊髓缺血(5.5% vs 2.8%;P = .022)均更高,脊髓缺血差异主要在II型胸腹主动脉瘤患者中(7.8% vs 3.0%;P = .025)。

临床怎么用

  • 应关注女性胸腹主动脉瘤患者二级预防用药不足的问题,优化阿司匹林和他汀的使用。
  • 女性动脉瘤更广泛且超过推荐阈值更大,需更积极评估和及时转诊。
  • 女性髂股入路复杂和入路并发症更高,术前应仔细评估入路血管。
  • 女性术后脊髓缺血风险更高,尤其是II型胸腹主动脉瘤,需加强脊髓保护策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previous studies have suggested unique challenges in treating women with thoracoabdominal aortic aneurysms (TAAAs) compared with their male counterparts. We sought to examine the real-world outcomes of complex endovascular aneurysm repair (cEVAR) for TAAA in women and men. METHODS: Patients undergoing cEVAR for type I to IV TAAAs between 2014 and 2020 were identified using the Vascular Quality Initiative database. Demographic, preoperative, and intraoperative variables, as well as postoperative outcomes, were compared between women and men. One-year survival after cEVAR was compared between women and men using the long-term follow-up data from the Vascular Quality Initiative. RESULTS: A total of 1128 patients underwent cEVAR for type I to IV TAAAs during the study period, of whom 417 (37%) were females. Women had more extensive aneurysms (84.7% vs 72.4% type I-III TAAA; P < .001) and were more likely to present with symptomatic aneurysm (26.1% vs 18.4%; P = .002) compared with men. Women were less likely to be on secondary cardiovascular preventative medications, including aspirin (59.4% vs 67.4%; P = .019) and statins (65.1% vs 73.1%; P = .012), more likely to be current smokers (36.1% vs 30.7%; P = .052), and treated at higher maximum diameter threshold (7.7 mm vs 4.6 mm above the recommended repair size; P < .001). Although there were no differences in operative time, women were more likely to have undergone a staged repair (22.3% vs 16.6%; P = .018) and have complicated iliofemoral access (19.2% vs 10.3%; P < .001) with a higher incidence of access complications (8.9% vs 5.2%; P = .016) compared with men. Thirty-day rates of mortality (11.8% vs 6.6%; P = .003) and overall complications (35.7% vs 25.7%; P < .001), including permanent spinal cord ischemia (5.5% vs 2.8%; P = .022) primarily among patients with type II TAAAs (7.8 vs 3.0%; P = .025), were all higher for women compared with men. One-year survival after cEVAR for TAAAs was significantly lower for women compared with men (74 vs 82%; P = .001), driven by the higher 30-day mortality rate in women. Female sex was an independent risk factor for both 30-day and 1-year mortality. CONCLUSIONS: This study demonstrated that women had higher 30-day morbidity and mortality and lower 1-year survival rates after cEVAR for type I to IV TAAAs compared with men. There were significant differences in presentation, anatomical features, and implementations of secondary cardiovascular preventative management, all likely affecting the differences in outcomes between women and men. Future studies are warranted to better understand these differences and optimize sex-specific approaches to management of TAAAs in women.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kang J, Thompson K, Mukherjee T, et al. Sex-related outcomes following endovascular repair of thoracoabdominal aortic aneurysm. J Vasc Surg. 2026. PMID: 41621462. doi:10.1016/j.jvs.2026.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。